Allurion Technologies (ALURW) Cash & Current Investments (2022 - 2026)
Allurion Technologies (ALURW) reported Cash & Current Investments of $5.1 million for Q1 2026, down 75.23% on a YoY basis from $20.4 million in Q1 2025, and down 6.58% quarter-over-quarter from $5.4 million in Q4 2025.
Allurion Technologies (ALURW) Cash & Current Investments (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Cash & Current Investments for 5 years, with the latest figure at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 75.23% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 75.23% YoY), and the FY2025 full-year result was $5.4 million, down 64.81% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $5.1 million, down from $5.4 million in the prior quarter.
- The five-year high for Cash & Current Investments was $79.9 million in Q3 2023, with the low at $4.7 million in Q2 2023.
- Historically, Cash & Current Investments has averaged $21.0 million across 5 years, with a median of $15.4 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Current Investments soared 394.95% — and 2025, when it tumbled 78.59%.
- Allurion Technologies' Cash & Current Investments stood at $7.7 million in 2022, then soared by 394.95% to $38.0 million in 2023, then plunged by 59.57% to $15.4 million in 2024, then sank by 64.81% to $5.4 million in 2025, then slipped by 6.58% to $5.1 million in 2026.
- The last three Cash & Current Investments figures came in at $5.1 million (Q1 2026), $5.4 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 5.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.06 Mn |
| Dec 31, 2025 | 5.41 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 12.72 Mn |
| Mar 31, 2025 | 20.41 Mn |
| Dec 31, 2024 | 15.38 Mn |
| Sep 30, 2024 | 28.65 Mn |
| Jun 30, 2024 | 19.26 Mn |
| Mar 31, 2024 | 29.68 Mn |
| Dec 31, 2023 | 38.04 Mn |
| Sep 30, 2023 | 79.87 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Dec 31, 2022 | 7.69 Mn |